Prostate Cancer: Drug Combo Lowers Death Risk by 40% in Aggressive Cases

Men with prostate cancer that returns after surgery or radiation and are left with few options could benefit from a new ...

Drug combo cuts risk of death in advanced prostate cancer by 40%, clinical trial finds

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...
Science Daily

This powerful drug combo cuts prostate cancer deaths by 40%

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...
The American Journal of Managed Care

Enzalutamide Combo Improves OS in Prostate Cancer Without Sacrificing Quality of Life: Stephen Freedland, MD

Stephen Freedland, MD, of Cedars-Sinai, discussed enzalutamide and leuprolide's potential to improve overall survival without ...

New imaging solution could help improve survival for patients with recurring prostate cancer

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...
Yahoo

My GP told me not to worry about my symptoms. Then I was diagnosed with stage two prostate cancer

John Taylor, 69, was denied a PSA blood test despite repeated urinary symptoms - Paul Cooper I didn’t know anything about prostate cancer when I first went to the doctor’s. I’d started noticing that I ...